02/12/2025
8:28 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
6:04 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
3:25 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
01/15/2025
3:08 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/13/2025
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/13/2025
3:09 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:04 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2025
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for RNAC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/10/2025
5:00 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form POS AM | |
01/10/2025
5:01 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form POS AM | |
01/08/2025
3:33 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025
3:38 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025
3:30 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 424B3 | |
01/07/2025
7:04 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Davis Blaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:04 PM | Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:05 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:05 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:05 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:05 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:21 PM | Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:14 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:11 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
7:22 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
4:20 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:16 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/11/2024
3:28 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:21 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
3:36 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
5:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
5:50 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
5:51 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
5:52 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:45 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
8:44 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
11/18/2024
6:28 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:35 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:23 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
11/18/2024
3:24 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:07 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
6:31 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:19 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:53 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:30 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
10/15/2024
3:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:08 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
10/04/2024
4:58 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
11:15 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form EFFECT | |
10/01/2024
3:36 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 424B7 | |
09/27/2024
3:13 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:20 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
09/26/2024
6:02 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
6:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:17 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-1/A | |
08/16/2024
3:02 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEF 14A | |
08/14/2024
3:41 PM | BARABE TIMOTHY C (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:40 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/08/2024
6:04 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:07 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:45 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form PRE 14A | |
08/02/2024
6:34 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/17/2024
10:45 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/12/2024
5:12 PM | Artal International S.C.A. (Filed by)
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
| Form SC 13G/A | |
07/05/2024
3:02 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:15 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
07/02/2024
5:30 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
6:54 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:08 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
9:03 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
05/08/2024
6:03 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
8:09 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:57 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:57 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
5:25 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:49 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
3:24 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
04/10/2024
8:47 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:35 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:40 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:43 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:30 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:33 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:20 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:25 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Singer Michael (Filed by)
| Form SC 13D/A | |
04/10/2024
3:29 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
Secret financial plot unfolding in Washington DC… [DEVELOPING] (Ad) What stocks are next up to soar in 2025?
I believe I’ve found the answer - and it might surprise you.
You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC… So please take a moment to watch it now. |
04/09/2024
6:00 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:32 PM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:27 PM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
03/26/2024
3:32 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:09 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:29 PM | Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
6:55 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
6:06 AM | Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
